trazodone ER / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

9 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
trazodone ER / Generic mfg.
SIESTA, NCT00027053: Trazodone for Sleep Disturbance in Early Alcohol Recovery

Completed
2
173
US
Trazodone, Placebo
Rhode Island Hospital, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Alcoholism
01/06
06/06
2007-002140-24: Open-label, Multicenter Clinical Study of Dose-dependent Efficacy and Safety of Trazodone Hydrochloride in Patients wirh Major Depressive Disorder ans Pain (TIPAD Study)

Completed
2
120
Europe
Trittico retard 75 mg, Trittico retard 150 mg, Trittico retard 75 mg, Trittico retard 150 mg
CSC Pharmaceuticals Handels GmbH.
Major Depression Disorder associated with painful physical symptoms
 
02/09
REST-SCI, NCT02458469: Role of Enhancing Serotonin Receptors Activity for Sleep Apnea Treatment in Patients With SCI

Completed
2
15
US
Buspirone, Trazodone, Placebo
VA Office of Research and Development
Spinal Cord Injury, Sleep Disordered Breathing
04/19
04/19
NCT04082806: Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.

Completed
2
54
Europe
GHB, Trazodone, Placebos
Erich Seifritz
Major Depressive Disorder
04/22
04/22
VicTor, NCT05793684: AD816 Crossover Study

Completed
2
25
US
Period A, Period B, Period C
Apnimed
OSA, Obstructive Sleep Apnea
11/23
11/23
REST, NCT05282550: Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

Recruiting
2
100
US
Trazodone, Desyrel, Placebo
Johns Hopkins University, National Institute on Aging (NIA)
AMCI - Amnestic Mild Cognitive Impairment, Sleep Disturbance
03/27
05/28
NCT01857596: Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety

Completed
1b/2a
30
US
bupropion, Lorexys low-dose, Lorexys moderate-dose, Lorexys is bupropion plus trazodone, Lorexys lower-dose is 225 mg per day., Lorexys moderate-dose is 450 mg per day.
S1 Biopharma, Inc.
Hypoactive Sexual Desire Disorder (DSM-IV-TR Defined), Sexual Interest/Arousal Disorder (DSM-5 Defined)
10/14
10/14
RescOSA, NCT05293600: Rescue Pharmacotherapy for OSA

Recruiting
1/2
70
US
Placebo, Acetazolamide, Trazodone, Atomoxetine and eszopiclone
Brigham and Women's Hospital
Obstructive Sleep Apnea
10/26
10/26
NCT06286189: Trazodone on OSA Endotypes

Recruiting
1/2
18
US
Placebo oral tablet, Trazodone Hydrochloride
Brigham and Women's Hospital
Obstructive Sleep Apnea
01/25
06/25

Download Options